Delisting riskPopularity #3,356
Tenon Medical (TNON)
SI-joint fusion implants delivered through complementary minimally invasive surgical approaches.
$3.45
After hours+0.01 (+0.37%)
At close$3.44(−7.91%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Gross profit | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | |
| Research & development | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
| 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 4 | 3 | 4 | 3 | |
| Selling & marketing | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 2 |
| General & administrative | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Operating income | −3 | −3 | −4 | −4 | −3 | −3 | −4 | −3 | −3 | −3 | −3 | −3 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −3 | −3 | −4 | −4 | −3 | −3 | −4 | −3 | −3 | −3 | −3 | −4 |
| Net income from continuing operations | −3 | −3 | −4 | −4 | −3 | −3 | −4 | −3 | −3 | −3 | −3 | −4 |
| Net income | −3 | −3 | −4 | −4 | −3 | −3 | −4 | −3 | −3 | −3 | −3 | −4 |
| EPS, basic | −$11.69 | −$344.75 | −$351.05 | −$285.60 | −$127.05 | −$88.90 | −$35.35 | −$12.60 | −$14.00 | −$9.10 | −$10.85 | −$12.35 |
| EPS, diluted | −$11.69 | −$344.75 | −$351.05 | −$285.60 | −$127.05 | −$88.90 | −$35.35 | −$12.60 | −$14.00 | −$9.10 | −$10.85 | −$12.35 |
| Weighted average shares, basic | 0 | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Weighted average shares, diluted | 0 | — | — | — | — | — | — | — | — | — | 0 | 0 |
| EBITDA | −3 | −3 | −3 | −4 | −3 | −3 | −4 | −3 | −3 | −3 | −3 | −4 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −3 | −3 | −4 | −4 | −3 | −3 | −4 | −3 | −3 | −3 | −3 | −4 |
